These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 9778651)

  • 1. Arachidonic acid modulation of [3H]naloxone specific binding to rat brain opioid receptors.
    Oktem HA; Apaydin S
    Neurobiology (Bp); 1998; 6(3):323-32. PubMed ID: 9778651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cation and guanine nucleotide effects on ligand binding properties of mu and delta opioid receptors in rat brain membranes.
    Benyhe S; Szücs M; Varga E; Simon J; Borsodi A; Wollemann M
    Acta Biochim Biophys Hung; 1989; 24(1-2):69-81. PubMed ID: 2558475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of a new opiate antagonist, nalmefene, to rat brain membranes.
    Michel ME; Bolger G; Weissman BA
    Methods Find Exp Clin Pharmacol; 1985 Apr; 7(4):175-7. PubMed ID: 2991678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha interferon interaction with opiate receptors in the rat brain].
    Panchenko LF; Aliab'eva TN; Malinovskaia VV; Balashov AM
    Biull Eksp Biol Med; 1987 Jul; 104(7):87-9. PubMed ID: 3040148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic analysis of rat brain opioid mu-receptor-ligand interaction.
    Zeman P; Tóth G; Kvetnanský R
    Gen Physiol Biophys; 1987 Jun; 6(3):237-48. PubMed ID: 3040520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of eptazocine, a novel analgesic, with opioid receptors.
    Nabeshima T; Matsuno K; Kamei H; Kameyama T
    Res Commun Chem Pathol Pharmacol; 1985 May; 48(2):173-81. PubMed ID: 2992058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive displacement binding assay on rat brain sections and using a beta-imager: application to mu-opioid ligands.
    Poisnel G; Quentin T; Barré L; Coquerel A; Debruyne D
    J Neurosci Methods; 2006 Jun; 154(1-2):60-7. PubMed ID: 16423409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
    Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
    Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
    Sim-Selley LJ; Xiao R; Childers SR
    Synapse; 2000 Mar; 35(4):256-64. PubMed ID: 10657035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory role of lysophosphatidic acid on opioid receptor binding.
    Apaydin S; Oktem HA
    Neurobiology (Bp); 1998; 6(4):421-7. PubMed ID: 10220777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific binding of 3H-naloxone with isolated rat enterocytes].
    Iarygin KN; Sviridov DD; Shitin AG; Vinogradov VA; Titov MI
    Biull Eksp Biol Med; 1985 Jul; 100(7):40-2. PubMed ID: 2990595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inactivation of naloxone binding with opioid receptors in rat brain membranes].
    Belokoneva OS; Mal'tseva EL; Zaĭtsev SV; Pal'mina NP
    Biokhimiia; 1993 Dec; 58(12):1945-58. PubMed ID: 8292655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoradiography in opioid triple knockout mice reveals opioid and opioid receptor like binding of naloxone benzoylhydrazone.
    Cox V; Clarke S; Czyzyk T; Ansonoff M; Nitsche J; Hsu MS; Borsodi A; Tömböly C; Tóth G; Hill R; Pintar J; Kitchen I
    Neuropharmacology; 2005 Feb; 48(2):228-35. PubMed ID: 15695161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of the putative epsilon opioid receptor: identification in rat, guinea pig, cow, pig and chicken brain.
    Nock B; Giordano AL; Moore BW; Cicero TJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):349-59. PubMed ID: 8380865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17.
    Blanchard SG; Lee PH; Pugh WW; Hong JS; Chang KJ
    Mol Pharmacol; 1987 Apr; 31(4):326-33. PubMed ID: 3033464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supraspinal delta- and mu-opioid receptors mediate gastric mucosal protection in the rat.
    Gyires K; Rónai AZ
    J Pharmacol Exp Ther; 2001 Jun; 297(3):1010-5. PubMed ID: 11356923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.